J J Mills

Author PubWeight™ 9.05^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Imprinted genes in liver carcinogenesis.	FASEB J	1997	1.22
2	Transforming growth factor-beta receptors and mannose 6-phosphate/insulin-like growth factor-II receptor expression in human hepatocellular carcinoma.	Ann Surg	1995	1.00
3	Modeling receptor-mediated processes with dioxin: implications for pharmacokinetics and risk assessment.	Risk Anal	1993	0.98
4	A multicompartment geometric model of the liver in relation to regional induction of cytochrome P450s.	Toxicol Appl Pharmacol	1997	0.94
5	Regulation and induction of CYP3A11, CYP3A13 and CYP3A25 in C57BL/6J mouse liver.	Arch Biochem Biophys	2006	0.87
6	A physiologically based pharmacokinetic model for 2,3,7,8-tetrabromodibenzo-p-dioxin (TBDD) in the rat: tissue distribution and CYP1A induction.	Toxicol Appl Pharmacol	1993	0.86
7	Mechanisms of hormonal carcinogenesis in the p53+/- hemizygous knockout mouse: studies with diethylstilbestrol.	Toxicol Pathol	2001	0.81
8	Negative selection in hepatic tumor promotion in relation to cancer risk assessment.	Toxicology	1995	0.78
9	Gene expression and cell proliferation in rat liver after 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure.	Cancer Res	1993	0.78
10	Phenobarbital selectively promotes initiated cells with reduced TGF beta receptor levels.	Carcinogenesis	1996	0.77
11	Receptor-mediated toxicity and implications for risk assessment.	Prog Clin Biol Res	1994	0.75